ATE378054T1 - Mittel zu linderung von hyperglykämie nach dem essen - Google Patents

Mittel zu linderung von hyperglykämie nach dem essen

Info

Publication number
ATE378054T1
ATE378054T1 AT02749378T AT02749378T ATE378054T1 AT E378054 T1 ATE378054 T1 AT E378054T1 AT 02749378 T AT02749378 T AT 02749378T AT 02749378 T AT02749378 T AT 02749378T AT E378054 T1 ATE378054 T1 AT E378054T1
Authority
AT
Austria
Prior art keywords
remedy
eating
levels reduced
cholesterol
hyperglycemia
Prior art date
Application number
AT02749378T
Other languages
English (en)
Inventor
Kenzo Oba
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Application granted granted Critical
Publication of ATE378054T1 publication Critical patent/ATE378054T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02749378T 2001-07-30 2002-07-29 Mittel zu linderung von hyperglykämie nach dem essen ATE378054T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001229087 2001-07-30

Publications (1)

Publication Number Publication Date
ATE378054T1 true ATE378054T1 (de) 2007-11-15

Family

ID=19061486

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02749378T ATE378054T1 (de) 2001-07-30 2002-07-29 Mittel zu linderung von hyperglykämie nach dem essen

Country Status (11)

Country Link
US (1) US7879869B2 (de)
EP (1) EP1413309B1 (de)
JP (1) JP4353414B2 (de)
KR (1) KR100924478B1 (de)
CN (1) CN1270724C (de)
AT (1) ATE378054T1 (de)
CA (1) CA2454732C (de)
DE (1) DE60223551T2 (de)
ES (1) ES2295369T3 (de)
TW (1) TWI324519B (de)
WO (1) WO2003011308A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
CA2560927C (en) * 2004-03-26 2013-05-14 Mitsubishi Pharma Corporation Insulin resistance-improving agent
WO2006041150A1 (ja) * 2004-10-15 2006-04-20 Mitsubishi Pharma Corporation 糖尿病の予防および／または治療薬
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US8986669B2 (en) 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
HUE026628T2 (en) 2005-09-15 2016-06-28 Genzyme Corp Pouches for amine polymers
WO2007145308A1 (ja) * 2006-06-16 2007-12-21 Mitsubishi Tanabe Pharma Corporation 糸球体疾患の予防及び/または治療剤
EP2066293A2 (de) 2006-09-29 2009-06-10 Genzyme Corporation Amid-dendrimer-zusammensetzungen
US8163799B2 (en) 2006-12-14 2012-04-24 Genzyme Corporation Amido-amine polymer compositions
US8524212B2 (en) 2007-10-24 2013-09-03 Mitsubishi Tanabe Pharma Corporation Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
CN102858347B (zh) * 2010-02-24 2016-11-02 瑞立普萨公司 用作胆汁酸螯合剂的聚咪唑
JP2014129284A (ja) * 2012-12-28 2014-07-10 Nof Corp 食後血糖上昇抑制剤
CN106366311B (zh) * 2015-07-23 2019-08-13 山东诚创医药技术开发有限公司 一种考来替兰的制备方法
CN106720731A (zh) * 2016-11-30 2017-05-31 广西百利乐生物科技有限公司 高透光率的果汁凉茶的浓缩提取液及其加工工艺
CN106359772A (zh) * 2016-11-30 2017-02-01 广西百利乐生物科技有限公司 防止沉淀的果汁凉茶的浓缩提取液及其加工方法
KR101969719B1 (ko) 2017-07-04 2019-04-17 한남대학교 산학협력단 리시닐-프럭토오즈(Lysinyl-Fructose, LF)를 포함하는 혈당상승 억제제 및 그 제조방법
KR102043461B1 (ko) 2017-12-21 2019-11-11 주식회사 프로테인웍스 아스코르빈산 및 니아신을 포함하는 식후 혈당상승억제용 조성물
KR20230057134A (ko) 2021-10-21 2023-04-28 한가람비앤에프 주식회사 해죽순 추출물을 포함하는 식후 혈당상승억제용 조성물
KR102450000B1 (ko) 2022-02-20 2022-09-30 이용호 커피 추출물을 포함하는 식후 혈당상승억제용 조성물
KR20230174959A (ko) 2022-06-22 2023-12-29 농업회사법인 그린생명주식회사 아마도리 화합물을 고농도로 함유하는 홍삼 추출물을 포함하는 식후 혈당상승억제용 조성물

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60209523A (ja) 1984-04-03 1985-10-22 Mitsubishi Petrochem Co Ltd コレステロ−ル低下剤
CA2052014A1 (en) 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
US5468727A (en) * 1990-12-13 1995-11-21 Board Of Regents, The University Of Texas System Methods of normalizing metabolic parameters in diabetics
US5607669A (en) * 1994-06-10 1997-03-04 Geltex Pharmaceuticals, Inc. Amine polymer sequestrant and method of cholesterol depletion
CA2129079C (en) * 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
US5496545A (en) 1993-08-11 1996-03-05 Geltex Pharmaceuticals, Inc. Phosphate-binding polymers for oral administration
DE69633502T2 (de) 1995-12-26 2006-02-23 Suntory Ltd. Procyanidin als den aktiven bestandteil enthaltende mittel gegen fettleibigkeit
US5847008A (en) * 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
EP0793960B1 (de) * 1996-03-05 2001-08-01 Mitsubishi Chemical Corporation Verwendung von Anionenaustauscherharzen zur Herstellung eines Arzneimittels zur Behandlung der Hyperphosphatemie
US6011049A (en) 1997-02-19 2000-01-04 Warner-Lambert Company Combinations for diabetes
ES2206868T3 (es) * 1998-07-15 2004-05-16 Merck Sante Comprimidos que comprenden una combinacion de metformin glibenclamida.
AU7856200A (en) * 1999-10-07 2001-05-10 University Of Maryland Sugar binding polymers and the use thereof
EP1307263B1 (de) * 2000-07-28 2005-04-20 F. Hoffmann-La Roche Ag Neue verwendung von lipase-inhibitoren
CN1273144C (zh) * 2000-11-28 2006-09-06 三菱制药株式会社 蓄积性含氯化合物的排泄促进剂

Also Published As

Publication number Publication date
CA2454732C (en) 2010-07-20
TWI324519B (en) 2010-05-11
CA2454732A1 (en) 2003-02-13
US20040191209A1 (en) 2004-09-30
CN1537010A (zh) 2004-10-13
EP1413309A1 (de) 2004-04-28
EP1413309B1 (de) 2007-11-14
CN1270724C (zh) 2006-08-23
DE60223551D1 (de) 2007-12-27
DE60223551T2 (de) 2008-10-23
JP4353414B2 (ja) 2009-10-28
WO2003011308A1 (en) 2003-02-13
US7879869B2 (en) 2011-02-01
ES2295369T3 (es) 2008-04-16
KR100924478B1 (ko) 2009-11-03
KR20040030858A (ko) 2004-04-09
JPWO2003011308A1 (ja) 2004-11-18
EP1413309A4 (de) 2006-06-07

Similar Documents

Publication Publication Date Title
ATE378054T1 (de) Mittel zu linderung von hyperglykämie nach dem essen
Brown et al. A review of the mechanism of action, metabolic profile and haemodynamic effects of sodium‐glucose co‐transporter‐2 inhibitors
BR0207700A (pt) Método para tratar a diabete melito em um paciente em necessidade de tal tratamento, e, usos de um derivado de polipeptìdeo de insulina, e de um conjugado de polipeptìdeo de insulina-oligÈmero
WO2001000223A3 (en) Multiple agent diabetes therapy
WO2002058684A3 (en) Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
UY26425A1 (es) Formulación y método antidiabético
NO20090846L (no) Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav
JP2004155791A (ja) 新規ｎｉｄｄｍ療法
MX9703694A (es) Tratamiento profilactico y terapeutico de la sensibilizacion e irritacion de la piel.
WO2001090091A8 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
NO20024924L (no) Anvendelse av bradykardiale substanser ved behandling av myokardiale sykdommer i forbindelse med hypertrofi og nyemedikamentkombinasjoner
Greenway et al. Double‐blind, randomized, placebo‐controlled clinical trials with non‐prescription medications for the treatment of obesity
BR0001794A (pt) Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares)
Woolf et al. Failure of rifampin to relieve pruritus in chronic liver disease
EP1393738A4 (de) Arzneimittel gegen diabetes
Cerasi et al. Effect Of Two Sulphonylureas On The Dose Kinetics Of Glucose–Induced Insulin Release In Normal And Diabetic Subjects
NO985676L (no) Forbindelser med colchicinstruktur, deres anvendelse som legemidler og blan
BR0103209A (pt) Uso de ácido fitânico para o tratamento de diabetes
NO985807D0 (no) Transdermale systemer inneholdende 2 aktive ingredienser i separate seksjoner, deres fremstillingsprosess og deres anvendelse som medikament
GB0606001D0 (en) Combination Of Cicletanine And An Oral Antidiabetic And/Or Blood Lipid-Lowering Agent For Treating Diabetes And Metabolic Syndrome
EP1447090B8 (de) Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen
BR0009704A (pt) Utilização do osanetant para a preparação de medicamentos úteis no tratamento das perturbações do humor
WO2003088953A3 (en) Multiphasic diet
DK2014290T3 (da) Anvendelse af tenatoprazol til behandling af gastroøsofageal refluks
St. Amand et al. The use of uricosuric agents in fibromyalgia: theory, practice, and a rebuttal to the Oregon study of guaifenesin treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties